These mixed findings of GLP-1 and its receptor agonists research in neurodegenerative diseases underscore the complexity of their role, highlighting the need for further research to clarify their potential impact on the pathology and prognosis of such conditions. Here, GLP1R is linked to neurodegenerative disease.